nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—schizophrenia—Dimenhydrinate—allergic rhinitis	0.182	0.363	CpDpCtD
Paliperidone—schizophrenia—Cyproheptadine—allergic rhinitis	0.182	0.363	CpDpCtD
Paliperidone—schizophrenia—Diphenhydramine—allergic rhinitis	0.138	0.275	CpDpCtD
Paliperidone—HRH1—Cetirizine—allergic rhinitis	0.0564	0.153	CbGbCtD
Paliperidone—HRH1—Dimenhydrinate—allergic rhinitis	0.0324	0.0879	CbGbCtD
Paliperidone—HTR2C—Cyproheptadine—allergic rhinitis	0.0278	0.0755	CbGbCtD
Paliperidone—HRH1—Desloratadine—allergic rhinitis	0.0275	0.0748	CbGbCtD
Paliperidone—HTR1A—Cyproheptadine—allergic rhinitis	0.0262	0.0711	CbGbCtD
Paliperidone—HRH1—Olopatadine—allergic rhinitis	0.0259	0.0703	CbGbCtD
Paliperidone—HTR2A—Cyproheptadine—allergic rhinitis	0.0251	0.068	CbGbCtD
Paliperidone—DRD2—Cyproheptadine—allergic rhinitis	0.0231	0.0627	CbGbCtD
Paliperidone—HRH1—Cyproheptadine—allergic rhinitis	0.0209	0.0567	CbGbCtD
Paliperidone—HRH1—Loratadine—allergic rhinitis	0.0158	0.0429	CbGbCtD
Paliperidone—HRH1—Diphenhydramine—allergic rhinitis	0.0158	0.0429	CbGbCtD
Paliperidone—CYP2D6—Desloratadine—allergic rhinitis	0.011	0.0299	CbGbCtD
Paliperidone—CYP3A4—Flunisolide—allergic rhinitis	0.00699	0.019	CbGbCtD
Paliperidone—CYP3A4—Olopatadine—allergic rhinitis	0.00657	0.0179	CbGbCtD
Paliperidone—CYP2D6—Loratadine—allergic rhinitis	0.00632	0.0171	CbGbCtD
Paliperidone—CYP2D6—Diphenhydramine—allergic rhinitis	0.00632	0.0171	CbGbCtD
Paliperidone—CYP3A5—Hydrocortisone—allergic rhinitis	0.00573	0.0156	CbGbCtD
Paliperidone—CYP3A4—Loratadine—allergic rhinitis	0.00402	0.0109	CbGbCtD
Paliperidone—CYP3A4—Montelukast—allergic rhinitis	0.00402	0.0109	CbGbCtD
Paliperidone—CYP3A4—Methylprednisolone—allergic rhinitis	0.00367	0.00997	CbGbCtD
Paliperidone—CYP3A5—Dexamethasone—allergic rhinitis	0.00356	0.00967	CbGbCtD
Paliperidone—CYP3A4—Triamcinolone—allergic rhinitis	0.00278	0.00756	CbGbCtD
Paliperidone—CYP3A4—Betamethasone—allergic rhinitis	0.00239	0.00648	CbGbCtD
Paliperidone—CYP3A4—Prednisolone—allergic rhinitis	0.00236	0.0064	CbGbCtD
Paliperidone—CYP3A4—Hydrocortisone—allergic rhinitis	0.00223	0.00607	CbGbCtD
Paliperidone—CYP2D6—Dexamethasone—allergic rhinitis	0.00218	0.00593	CbGbCtD
Paliperidone—CYP3A4—Dexamethasone—allergic rhinitis	0.00139	0.00377	CbGbCtD
Paliperidone—Immune system disorder—Methylprednisolone—allergic rhinitis	4.35e-05	0.000375	CcSEcCtD
Paliperidone—Mediastinal disorder—Methylprednisolone—allergic rhinitis	4.34e-05	0.000375	CcSEcCtD
Paliperidone—Vision blurred—Prednisolone—allergic rhinitis	4.3e-05	0.000372	CcSEcCtD
Paliperidone—Vomiting—Montelukast—allergic rhinitis	4.28e-05	0.00037	CcSEcCtD
Paliperidone—Rash—Montelukast—allergic rhinitis	4.25e-05	0.000367	CcSEcCtD
Paliperidone—Dermatitis—Montelukast—allergic rhinitis	4.24e-05	0.000367	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisolone—allergic rhinitis	4.23e-05	0.000366	CcSEcCtD
Paliperidone—Headache—Montelukast—allergic rhinitis	4.22e-05	0.000365	CcSEcCtD
Paliperidone—Mental disorder—Methylprednisolone—allergic rhinitis	4.21e-05	0.000364	CcSEcCtD
Paliperidone—Erythema—Triamcinolone—allergic rhinitis	4.2e-05	0.000363	CcSEcCtD
Paliperidone—Malnutrition—Methylprednisolone—allergic rhinitis	4.19e-05	0.000362	CcSEcCtD
Paliperidone—Erythema—Methylprednisolone—allergic rhinitis	4.19e-05	0.000362	CcSEcCtD
Paliperidone—Angioedema—Prednisolone—allergic rhinitis	4.17e-05	0.00036	CcSEcCtD
Paliperidone—Ill-defined disorder—Hydrocortisone—allergic rhinitis	4.14e-05	0.000357	CcSEcCtD
Paliperidone—Malaise—Prednisolone—allergic rhinitis	4.12e-05	0.000356	CcSEcCtD
Paliperidone—Dysgeusia—Triamcinolone—allergic rhinitis	4.11e-05	0.000355	CcSEcCtD
Paliperidone—Vertigo—Prednisolone—allergic rhinitis	4.1e-05	0.000354	CcSEcCtD
Paliperidone—Syncope—Prednisolone—allergic rhinitis	4.09e-05	0.000354	CcSEcCtD
Paliperidone—Eye disorder—Betamethasone—allergic rhinitis	4.09e-05	0.000353	CcSEcCtD
Paliperidone—Eye disorder—Dexamethasone—allergic rhinitis	4.09e-05	0.000353	CcSEcCtD
Paliperidone—Angioedema—Hydrocortisone—allergic rhinitis	4.07e-05	0.000352	CcSEcCtD
Paliperidone—Back pain—Triamcinolone—allergic rhinitis	4.06e-05	0.000351	CcSEcCtD
Paliperidone—Malaise—Hydrocortisone—allergic rhinitis	4.02e-05	0.000347	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisolone—allergic rhinitis	4.01e-05	0.000347	CcSEcCtD
Paliperidone—Vertigo—Hydrocortisone—allergic rhinitis	4e-05	0.000346	CcSEcCtD
Paliperidone—Nausea—Montelukast—allergic rhinitis	4e-05	0.000346	CcSEcCtD
Paliperidone—Syncope—Hydrocortisone—allergic rhinitis	4e-05	0.000345	CcSEcCtD
Paliperidone—Angiopathy—Dexamethasone—allergic rhinitis	3.97e-05	0.000343	CcSEcCtD
Paliperidone—Angiopathy—Betamethasone—allergic rhinitis	3.97e-05	0.000343	CcSEcCtD
Paliperidone—Convulsion—Prednisolone—allergic rhinitis	3.95e-05	0.000342	CcSEcCtD
Paliperidone—Hypertension—Prednisolone—allergic rhinitis	3.94e-05	0.00034	CcSEcCtD
Paliperidone—Loss of consciousness—Hydrocortisone—allergic rhinitis	3.92e-05	0.000339	CcSEcCtD
Paliperidone—Ill-defined disorder—Triamcinolone—allergic rhinitis	3.89e-05	0.000336	CcSEcCtD
Paliperidone—Ill-defined disorder—Methylprednisolone—allergic rhinitis	3.89e-05	0.000336	CcSEcCtD
Paliperidone—Alopecia—Dexamethasone—allergic rhinitis	3.87e-05	0.000334	CcSEcCtD
Paliperidone—Alopecia—Betamethasone—allergic rhinitis	3.87e-05	0.000334	CcSEcCtD
Paliperidone—Convulsion—Hydrocortisone—allergic rhinitis	3.86e-05	0.000334	CcSEcCtD
Paliperidone—Hypertension—Hydrocortisone—allergic rhinitis	3.85e-05	0.000333	CcSEcCtD
Paliperidone—Discomfort—Prednisolone—allergic rhinitis	3.84e-05	0.000332	CcSEcCtD
Paliperidone—Angioedema—Triamcinolone—allergic rhinitis	3.84e-05	0.000331	CcSEcCtD
Paliperidone—Angioedema—Methylprednisolone—allergic rhinitis	3.83e-05	0.000331	CcSEcCtD
Paliperidone—Erythema—Dexamethasone—allergic rhinitis	3.81e-05	0.000329	CcSEcCtD
Paliperidone—Erythema—Betamethasone—allergic rhinitis	3.81e-05	0.000329	CcSEcCtD
Paliperidone—Myalgia—Hydrocortisone—allergic rhinitis	3.79e-05	0.000328	CcSEcCtD
Paliperidone—Malaise—Triamcinolone—allergic rhinitis	3.78e-05	0.000327	CcSEcCtD
Paliperidone—Anxiety—Hydrocortisone—allergic rhinitis	3.78e-05	0.000327	CcSEcCtD
Paliperidone—Malaise—Methylprednisolone—allergic rhinitis	3.78e-05	0.000326	CcSEcCtD
Paliperidone—Vertigo—Triamcinolone—allergic rhinitis	3.77e-05	0.000326	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	3.77e-05	0.000326	CcSEcCtD
Paliperidone—Syncope—Triamcinolone—allergic rhinitis	3.76e-05	0.000325	CcSEcCtD
Paliperidone—Vertigo—Methylprednisolone—allergic rhinitis	3.76e-05	0.000325	CcSEcCtD
Paliperidone—Syncope—Methylprednisolone—allergic rhinitis	3.76e-05	0.000324	CcSEcCtD
Paliperidone—Discomfort—Hydrocortisone—allergic rhinitis	3.75e-05	0.000324	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisolone—allergic rhinitis	3.72e-05	0.000322	CcSEcCtD
Paliperidone—Oedema—Prednisolone—allergic rhinitis	3.72e-05	0.000322	CcSEcCtD
Paliperidone—Loss of consciousness—Triamcinolone—allergic rhinitis	3.69e-05	0.000319	CcSEcCtD
Paliperidone—Loss of consciousness—Methylprednisolone—allergic rhinitis	3.68e-05	0.000318	CcSEcCtD
Paliperidone—Shock—Prednisolone—allergic rhinitis	3.66e-05	0.000317	CcSEcCtD
Paliperidone—Cough—Triamcinolone—allergic rhinitis	3.66e-05	0.000316	CcSEcCtD
Paliperidone—Anaphylactic shock—Hydrocortisone—allergic rhinitis	3.64e-05	0.000314	CcSEcCtD
Paliperidone—Oedema—Hydrocortisone—allergic rhinitis	3.64e-05	0.000314	CcSEcCtD
Paliperidone—Convulsion—Triamcinolone—allergic rhinitis	3.64e-05	0.000314	CcSEcCtD
Paliperidone—Tachycardia—Prednisolone—allergic rhinitis	3.64e-05	0.000314	CcSEcCtD
Paliperidone—Convulsion—Methylprednisolone—allergic rhinitis	3.63e-05	0.000314	CcSEcCtD
Paliperidone—Hypertension—Triamcinolone—allergic rhinitis	3.62e-05	0.000313	CcSEcCtD
Paliperidone—Hypertension—Methylprednisolone—allergic rhinitis	3.62e-05	0.000312	CcSEcCtD
Paliperidone—Infection—Hydrocortisone—allergic rhinitis	3.61e-05	0.000312	CcSEcCtD
Paliperidone—Shock—Hydrocortisone—allergic rhinitis	3.58e-05	0.000309	CcSEcCtD
Paliperidone—Myalgia—Triamcinolone—allergic rhinitis	3.57e-05	0.000309	CcSEcCtD
Paliperidone—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.57e-05	0.000308	CcSEcCtD
Paliperidone—Myalgia—Methylprednisolone—allergic rhinitis	3.57e-05	0.000308	CcSEcCtD
Paliperidone—Arthralgia—Methylprednisolone—allergic rhinitis	3.57e-05	0.000308	CcSEcCtD
Paliperidone—Anxiety—Methylprednisolone—allergic rhinitis	3.55e-05	0.000307	CcSEcCtD
Paliperidone—Tachycardia—Hydrocortisone—allergic rhinitis	3.55e-05	0.000307	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.54e-05	0.000306	CcSEcCtD
Paliperidone—Skin disorder—Hydrocortisone—allergic rhinitis	3.53e-05	0.000305	CcSEcCtD
Paliperidone—Ill-defined disorder—Betamethasone—allergic rhinitis	3.53e-05	0.000305	CcSEcCtD
Paliperidone—Ill-defined disorder—Dexamethasone—allergic rhinitis	3.53e-05	0.000305	CcSEcCtD
Paliperidone—Discomfort—Triamcinolone—allergic rhinitis	3.53e-05	0.000305	CcSEcCtD
Paliperidone—Discomfort—Methylprednisolone—allergic rhinitis	3.52e-05	0.000304	CcSEcCtD
Paliperidone—Dry mouth—Triamcinolone—allergic rhinitis	3.49e-05	0.000302	CcSEcCtD
Paliperidone—Angioedema—Betamethasone—allergic rhinitis	3.48e-05	0.000301	CcSEcCtD
Paliperidone—Angioedema—Dexamethasone—allergic rhinitis	3.48e-05	0.000301	CcSEcCtD
Paliperidone—Anorexia—Hydrocortisone—allergic rhinitis	3.47e-05	0.0003	CcSEcCtD
Paliperidone—Confusional state—Methylprednisolone—allergic rhinitis	3.45e-05	0.000298	CcSEcCtD
Paliperidone—Malaise—Dexamethasone—allergic rhinitis	3.43e-05	0.000297	CcSEcCtD
Paliperidone—Malaise—Betamethasone—allergic rhinitis	3.43e-05	0.000297	CcSEcCtD
Paliperidone—Anaphylactic shock—Triamcinolone—allergic rhinitis	3.43e-05	0.000296	CcSEcCtD
Paliperidone—Oedema—Triamcinolone—allergic rhinitis	3.43e-05	0.000296	CcSEcCtD
Paliperidone—Vertigo—Betamethasone—allergic rhinitis	3.42e-05	0.000296	CcSEcCtD
Paliperidone—Vertigo—Dexamethasone—allergic rhinitis	3.42e-05	0.000296	CcSEcCtD
Paliperidone—Anaphylactic shock—Methylprednisolone—allergic rhinitis	3.42e-05	0.000295	CcSEcCtD
Paliperidone—Syncope—Dexamethasone—allergic rhinitis	3.42e-05	0.000295	CcSEcCtD
Paliperidone—Syncope—Betamethasone—allergic rhinitis	3.42e-05	0.000295	CcSEcCtD
Paliperidone—Infection—Triamcinolone—allergic rhinitis	3.4e-05	0.000294	CcSEcCtD
Paliperidone—Hypotension—Hydrocortisone—allergic rhinitis	3.4e-05	0.000294	CcSEcCtD
Paliperidone—Infection—Methylprednisolone—allergic rhinitis	3.4e-05	0.000293	CcSEcCtD
Paliperidone—Shock—Triamcinolone—allergic rhinitis	3.37e-05	0.000291	CcSEcCtD
Paliperidone—Insomnia—Prednisolone—allergic rhinitis	3.37e-05	0.000291	CcSEcCtD
Paliperidone—Shock—Methylprednisolone—allergic rhinitis	3.36e-05	0.000291	CcSEcCtD
Paliperidone—Nervous system disorder—Methylprednisolone—allergic rhinitis	3.35e-05	0.00029	CcSEcCtD
Paliperidone—Loss of consciousness—Dexamethasone—allergic rhinitis	3.35e-05	0.000289	CcSEcCtD
Paliperidone—Loss of consciousness—Betamethasone—allergic rhinitis	3.35e-05	0.000289	CcSEcCtD
Paliperidone—Paraesthesia—Prednisolone—allergic rhinitis	3.34e-05	0.000289	CcSEcCtD
Paliperidone—Tachycardia—Triamcinolone—allergic rhinitis	3.34e-05	0.000289	CcSEcCtD
Paliperidone—Tachycardia—Methylprednisolone—allergic rhinitis	3.34e-05	0.000288	CcSEcCtD
Paliperidone—Skin disorder—Methylprednisolone—allergic rhinitis	3.32e-05	0.000287	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	3.31e-05	0.000286	CcSEcCtD
Paliperidone—Convulsion—Dexamethasone—allergic rhinitis	3.3e-05	0.000285	CcSEcCtD
Paliperidone—Convulsion—Betamethasone—allergic rhinitis	3.3e-05	0.000285	CcSEcCtD
Paliperidone—Insomnia—Hydrocortisone—allergic rhinitis	3.29e-05	0.000284	CcSEcCtD
Paliperidone—Hypertension—Dexamethasone—allergic rhinitis	3.29e-05	0.000284	CcSEcCtD
Paliperidone—Hypertension—Betamethasone—allergic rhinitis	3.29e-05	0.000284	CcSEcCtD
Paliperidone—Paraesthesia—Hydrocortisone—allergic rhinitis	3.27e-05	0.000282	CcSEcCtD
Paliperidone—Myalgia—Betamethasone—allergic rhinitis	3.24e-05	0.00028	CcSEcCtD
Paliperidone—Myalgia—Dexamethasone—allergic rhinitis	3.24e-05	0.00028	CcSEcCtD
Paliperidone—Anxiety—Betamethasone—allergic rhinitis	3.23e-05	0.000279	CcSEcCtD
Paliperidone—Anxiety—Dexamethasone—allergic rhinitis	3.23e-05	0.000279	CcSEcCtD
Paliperidone—Discomfort—Dexamethasone—allergic rhinitis	3.2e-05	0.000277	CcSEcCtD
Paliperidone—Discomfort—Betamethasone—allergic rhinitis	3.2e-05	0.000277	CcSEcCtD
Paliperidone—Dyspepsia—Hydrocortisone—allergic rhinitis	3.2e-05	0.000277	CcSEcCtD
Paliperidone—Hypotension—Methylprednisolone—allergic rhinitis	3.19e-05	0.000276	CcSEcCtD
Paliperidone—Pain—Prednisolone—allergic rhinitis	3.19e-05	0.000275	CcSEcCtD
Paliperidone—Decreased appetite—Hydrocortisone—allergic rhinitis	3.16e-05	0.000273	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	3.14e-05	0.000271	CcSEcCtD
Paliperidone—Fatigue—Hydrocortisone—allergic rhinitis	3.14e-05	0.000271	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	3.12e-05	0.00027	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	3.11e-05	0.000269	CcSEcCtD
Paliperidone—Pain—Hydrocortisone—allergic rhinitis	3.11e-05	0.000269	CcSEcCtD
Paliperidone—Anaphylactic shock—Betamethasone—allergic rhinitis	3.11e-05	0.000269	CcSEcCtD
Paliperidone—Oedema—Betamethasone—allergic rhinitis	3.11e-05	0.000269	CcSEcCtD
Paliperidone—Oedema—Dexamethasone—allergic rhinitis	3.11e-05	0.000269	CcSEcCtD
Paliperidone—Anaphylactic shock—Dexamethasone—allergic rhinitis	3.11e-05	0.000269	CcSEcCtD
Paliperidone—Insomnia—Triamcinolone—allergic rhinitis	3.1e-05	0.000268	CcSEcCtD
Paliperidone—Insomnia—Methylprednisolone—allergic rhinitis	3.09e-05	0.000267	CcSEcCtD
Paliperidone—Infection—Betamethasone—allergic rhinitis	3.09e-05	0.000267	CcSEcCtD
Paliperidone—Infection—Dexamethasone—allergic rhinitis	3.09e-05	0.000267	CcSEcCtD
Paliperidone—Paraesthesia—Triamcinolone—allergic rhinitis	3.08e-05	0.000266	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisolone—allergic rhinitis	3.07e-05	0.000265	CcSEcCtD
Paliperidone—Paraesthesia—Methylprednisolone—allergic rhinitis	3.07e-05	0.000265	CcSEcCtD
Paliperidone—Shock—Dexamethasone—allergic rhinitis	3.06e-05	0.000264	CcSEcCtD
Paliperidone—Shock—Betamethasone—allergic rhinitis	3.06e-05	0.000264	CcSEcCtD
Paliperidone—Dyspnoea—Triamcinolone—allergic rhinitis	3.05e-05	0.000264	CcSEcCtD
Paliperidone—Nervous system disorder—Betamethasone—allergic rhinitis	3.05e-05	0.000263	CcSEcCtD
Paliperidone—Nervous system disorder—Dexamethasone—allergic rhinitis	3.05e-05	0.000263	CcSEcCtD
Paliperidone—Thrombocytopenia—Betamethasone—allergic rhinitis	3.04e-05	0.000263	CcSEcCtD
Paliperidone—Thrombocytopenia—Dexamethasone—allergic rhinitis	3.04e-05	0.000263	CcSEcCtD
Paliperidone—Tachycardia—Betamethasone—allergic rhinitis	3.03e-05	0.000262	CcSEcCtD
Paliperidone—Tachycardia—Dexamethasone—allergic rhinitis	3.03e-05	0.000262	CcSEcCtD
Paliperidone—Dyspepsia—Triamcinolone—allergic rhinitis	3.02e-05	0.000261	CcSEcCtD
Paliperidone—Dyspepsia—Methylprednisolone—allergic rhinitis	3.01e-05	0.00026	CcSEcCtD
Paliperidone—Feeling abnormal—Hydrocortisone—allergic rhinitis	3e-05	0.000259	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	2.97e-05	0.000257	CcSEcCtD
Paliperidone—Anorexia—Betamethasone—allergic rhinitis	2.96e-05	0.000256	CcSEcCtD
Paliperidone—Anorexia—Dexamethasone—allergic rhinitis	2.96e-05	0.000256	CcSEcCtD
Paliperidone—Urticaria—Prednisolone—allergic rhinitis	2.96e-05	0.000256	CcSEcCtD
Paliperidone—Fatigue—Triamcinolone—allergic rhinitis	2.95e-05	0.000255	CcSEcCtD
Paliperidone—Fatigue—Methylprednisolone—allergic rhinitis	2.95e-05	0.000255	CcSEcCtD
Paliperidone—Pain—Triamcinolone—allergic rhinitis	2.93e-05	0.000253	CcSEcCtD
Paliperidone—Hypotension—Dexamethasone—allergic rhinitis	2.9e-05	0.000251	CcSEcCtD
Paliperidone—Hypotension—Betamethasone—allergic rhinitis	2.9e-05	0.000251	CcSEcCtD
Paliperidone—Urticaria—Hydrocortisone—allergic rhinitis	2.89e-05	0.00025	CcSEcCtD
Paliperidone—Abdominal pain—Hydrocortisone—allergic rhinitis	2.88e-05	0.000248	CcSEcCtD
Paliperidone—Body temperature increased—Hydrocortisone—allergic rhinitis	2.88e-05	0.000248	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	2.83e-05	0.000245	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	2.83e-05	0.000245	CcSEcCtD
Paliperidone—Feeling abnormal—Triamcinolone—allergic rhinitis	2.82e-05	0.000244	CcSEcCtD
Paliperidone—Feeling abnormal—Methylprednisolone—allergic rhinitis	2.82e-05	0.000243	CcSEcCtD
Paliperidone—Insomnia—Dexamethasone—allergic rhinitis	2.81e-05	0.000243	CcSEcCtD
Paliperidone—Insomnia—Betamethasone—allergic rhinitis	2.81e-05	0.000243	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	2.79e-05	0.000241	CcSEcCtD
Paliperidone—Paraesthesia—Betamethasone—allergic rhinitis	2.79e-05	0.000241	CcSEcCtD
Paliperidone—Paraesthesia—Dexamethasone—allergic rhinitis	2.79e-05	0.000241	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisolone—allergic rhinitis	2.74e-05	0.000237	CcSEcCtD
Paliperidone—Dyspepsia—Betamethasone—allergic rhinitis	2.74e-05	0.000236	CcSEcCtD
Paliperidone—Dyspepsia—Dexamethasone—allergic rhinitis	2.74e-05	0.000236	CcSEcCtD
Paliperidone—Urticaria—Triamcinolone—allergic rhinitis	2.72e-05	0.000235	CcSEcCtD
Paliperidone—Urticaria—Methylprednisolone—allergic rhinitis	2.72e-05	0.000235	CcSEcCtD
Paliperidone—Body temperature increased—Triamcinolone—allergic rhinitis	2.71e-05	0.000234	CcSEcCtD
Paliperidone—Abdominal pain—Methylprednisolone—allergic rhinitis	2.7e-05	0.000233	CcSEcCtD
Paliperidone—Decreased appetite—Dexamethasone—allergic rhinitis	2.7e-05	0.000233	CcSEcCtD
Paliperidone—Decreased appetite—Betamethasone—allergic rhinitis	2.7e-05	0.000233	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.68e-05	0.000232	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.68e-05	0.000232	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.68e-05	0.000232	CcSEcCtD
Paliperidone—Fatigue—Betamethasone—allergic rhinitis	2.68e-05	0.000232	CcSEcCtD
Paliperidone—Fatigue—Dexamethasone—allergic rhinitis	2.68e-05	0.000232	CcSEcCtD
Paliperidone—Pain—Dexamethasone—allergic rhinitis	2.66e-05	0.00023	CcSEcCtD
Paliperidone—Pain—Betamethasone—allergic rhinitis	2.66e-05	0.00023	CcSEcCtD
Paliperidone—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	2.65e-05	0.0018	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.65e-05	0.0018	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.62e-05	0.00178	CbGpPWpGaD
Paliperidone—Asthenia—Hydrocortisone—allergic rhinitis	2.61e-05	0.000226	CcSEcCtD
Paliperidone—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	2.61e-05	0.00177	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—PTGDR2—allergic rhinitis	2.6e-05	0.00176	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	2.6e-05	0.00176	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.59e-05	0.00176	CbGpPWpGaD
Paliperidone—Pruritus—Hydrocortisone—allergic rhinitis	2.57e-05	0.000222	CcSEcCtD
Paliperidone—Feeling abnormal—Dexamethasone—allergic rhinitis	2.56e-05	0.000221	CcSEcCtD
Paliperidone—Feeling abnormal—Betamethasone—allergic rhinitis	2.56e-05	0.000221	CcSEcCtD
Paliperidone—DRD4—Signaling by GPCR—CCL11—allergic rhinitis	2.55e-05	0.00174	CbGpPWpGaD
Paliperidone—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.54e-05	0.00022	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.54e-05	0.00022	CcSEcCtD
Paliperidone—ADRA2C—Signaling by GPCR—PTGDR2—allergic rhinitis	2.52e-05	0.00172	CbGpPWpGaD
Paliperidone—Hypersensitivity—Triamcinolone—allergic rhinitis	2.52e-05	0.000218	CcSEcCtD
Paliperidone—DRD2—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.52e-05	0.00171	CbGpPWpGaD
Paliperidone—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.52e-05	0.000218	CcSEcCtD
Paliperidone—Diarrhoea—Hydrocortisone—allergic rhinitis	2.49e-05	0.000215	CcSEcCtD
Paliperidone—ADRA1B—Signaling by GPCR—PTGDR2—allergic rhinitis	2.49e-05	0.00169	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.48e-05	0.00169	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.48e-05	0.00168	CbGpPWpGaD
Paliperidone—Urticaria—Betamethasone—allergic rhinitis	2.47e-05	0.000213	CcSEcCtD
Paliperidone—Urticaria—Dexamethasone—allergic rhinitis	2.47e-05	0.000213	CcSEcCtD
Paliperidone—Dizziness—Prednisolone—allergic rhinitis	2.46e-05	0.000213	CcSEcCtD
Paliperidone—DRD2—GPCR ligand binding—TAC1—allergic rhinitis	2.46e-05	0.00167	CbGpPWpGaD
Paliperidone—Asthenia—Triamcinolone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Paliperidone—Body temperature increased—Betamethasone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Paliperidone—Body temperature increased—Dexamethasone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Paliperidone—Abdominal pain—Dexamethasone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Paliperidone—Abdominal pain—Betamethasone—allergic rhinitis	2.46e-05	0.000212	CcSEcCtD
Paliperidone—Asthenia—Methylprednisolone—allergic rhinitis	2.45e-05	0.000212	CcSEcCtD
Paliperidone—ADRA1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.43e-05	0.00165	CbGpPWpGaD
Paliperidone—Pruritus—Triamcinolone—allergic rhinitis	2.42e-05	0.000209	CcSEcCtD
Paliperidone—HTR2A—GPCR ligand binding—TAC1—allergic rhinitis	2.42e-05	0.00164	CbGpPWpGaD
Paliperidone—Pruritus—Methylprednisolone—allergic rhinitis	2.42e-05	0.000209	CcSEcCtD
Paliperidone—HRH1—GPCR ligand binding—TAC1—allergic rhinitis	2.41e-05	0.00164	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—IL5—allergic rhinitis	2.41e-05	0.00164	CbGpPWpGaD
Paliperidone—Dizziness—Hydrocortisone—allergic rhinitis	2.41e-05	0.000208	CcSEcCtD
Paliperidone—DRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.38e-05	0.00162	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—TAC1—allergic rhinitis	2.37e-05	0.00161	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.35e-05	0.0016	CbGpPWpGaD
Paliperidone—Rash—Prednisolone—allergic rhinitis	2.35e-05	0.000203	CcSEcCtD
Paliperidone—Dermatitis—Prednisolone—allergic rhinitis	2.35e-05	0.000203	CcSEcCtD
Paliperidone—Diarrhoea—Methylprednisolone—allergic rhinitis	2.34e-05	0.000202	CcSEcCtD
Paliperidone—ADRA2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.34e-05	0.00159	CbGpPWpGaD
Paliperidone—Headache—Prednisolone—allergic rhinitis	2.33e-05	0.000202	CcSEcCtD
Paliperidone—Vomiting—Hydrocortisone—allergic rhinitis	2.31e-05	0.0002	CcSEcCtD
Paliperidone—DRD1—Signaling by GPCR—CCL11—allergic rhinitis	2.3e-05	0.00156	CbGpPWpGaD
Paliperidone—Rash—Hydrocortisone—allergic rhinitis	2.29e-05	0.000198	CcSEcCtD
Paliperidone—Dermatitis—Hydrocortisone—allergic rhinitis	2.29e-05	0.000198	CcSEcCtD
Paliperidone—DRD2—Signaling by GPCR—PTGDR2—allergic rhinitis	2.29e-05	0.00156	CbGpPWpGaD
Paliperidone—Headache—Hydrocortisone—allergic rhinitis	2.28e-05	0.000197	CcSEcCtD
Paliperidone—DRD3—Signaling by GPCR—CCL11—allergic rhinitis	2.27e-05	0.00154	CbGpPWpGaD
Paliperidone—Dizziness—Triamcinolone—allergic rhinitis	2.27e-05	0.000196	CcSEcCtD
Paliperidone—Dizziness—Methylprednisolone—allergic rhinitis	2.26e-05	0.000195	CcSEcCtD
Paliperidone—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.26e-05	0.00153	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.25e-05	0.00153	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—PTGDR2—allergic rhinitis	2.25e-05	0.00153	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—IL5—allergic rhinitis	2.25e-05	0.00153	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—PTGDR2—allergic rhinitis	2.25e-05	0.00153	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.24e-05	0.00152	CbGpPWpGaD
Paliperidone—Asthenia—Dexamethasone—allergic rhinitis	2.23e-05	0.000193	CcSEcCtD
Paliperidone—Asthenia—Betamethasone—allergic rhinitis	2.23e-05	0.000193	CcSEcCtD
Paliperidone—Nausea—Prednisolone—allergic rhinitis	2.21e-05	0.000191	CcSEcCtD
Paliperidone—ADRA1A—Signaling by GPCR—PTGDR2—allergic rhinitis	2.21e-05	0.0015	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	2.2e-05	0.0015	CbGpPWpGaD
Paliperidone—Pruritus—Dexamethasone—allergic rhinitis	2.2e-05	0.00019	CcSEcCtD
Paliperidone—Pruritus—Betamethasone—allergic rhinitis	2.2e-05	0.00019	CcSEcCtD
Paliperidone—ADRA2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.18e-05	0.00148	CbGpPWpGaD
Paliperidone—Vomiting—Triamcinolone—allergic rhinitis	2.18e-05	0.000188	CcSEcCtD
Paliperidone—Vomiting—Methylprednisolone—allergic rhinitis	2.17e-05	0.000188	CcSEcCtD
Paliperidone—Nausea—Hydrocortisone—allergic rhinitis	2.16e-05	0.000187	CcSEcCtD
Paliperidone—Rash—Triamcinolone—allergic rhinitis	2.16e-05	0.000187	CcSEcCtD
Paliperidone—Dermatitis—Triamcinolone—allergic rhinitis	2.16e-05	0.000186	CcSEcCtD
Paliperidone—Rash—Methylprednisolone—allergic rhinitis	2.15e-05	0.000186	CcSEcCtD
Paliperidone—Dermatitis—Methylprednisolone—allergic rhinitis	2.15e-05	0.000186	CcSEcCtD
Paliperidone—ADRA1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.15e-05	0.00146	CbGpPWpGaD
Paliperidone—Headache—Triamcinolone—allergic rhinitis	2.15e-05	0.000185	CcSEcCtD
Paliperidone—Headache—Methylprednisolone—allergic rhinitis	2.14e-05	0.000185	CcSEcCtD
Paliperidone—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	2.13e-05	0.00145	CbGpPWpGaD
Paliperidone—Diarrhoea—Betamethasone—allergic rhinitis	2.13e-05	0.000184	CcSEcCtD
Paliperidone—Diarrhoea—Dexamethasone—allergic rhinitis	2.13e-05	0.000184	CcSEcCtD
Paliperidone—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	2.12e-05	0.00144	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.12e-05	0.00144	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	2.08e-05	0.00141	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	2.07e-05	0.0014	CbGpPWpGaD
Paliperidone—Dizziness—Dexamethasone—allergic rhinitis	2.06e-05	0.000178	CcSEcCtD
Paliperidone—Dizziness—Betamethasone—allergic rhinitis	2.06e-05	0.000178	CcSEcCtD
Paliperidone—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	2.05e-05	0.00139	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CCL11—allergic rhinitis	2.05e-05	0.00139	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.05e-05	0.00139	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—TAC1—allergic rhinitis	2.04e-05	0.00139	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.04e-05	0.00138	CbGpPWpGaD
Paliperidone—Nausea—Triamcinolone—allergic rhinitis	2.03e-05	0.000176	CcSEcCtD
Paliperidone—Nausea—Methylprednisolone—allergic rhinitis	2.03e-05	0.000175	CcSEcCtD
Paliperidone—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	2.02e-05	0.00137	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PTGDR2—allergic rhinitis	1.99e-05	0.00135	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.98e-05	0.00135	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.98e-05	0.00135	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	1.98e-05	0.00134	CbGpPWpGaD
Paliperidone—Vomiting—Betamethasone—allergic rhinitis	1.98e-05	0.000171	CcSEcCtD
Paliperidone—Vomiting—Dexamethasone—allergic rhinitis	1.98e-05	0.000171	CcSEcCtD
Paliperidone—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	1.97e-05	0.00134	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CCL11—allergic rhinitis	1.97e-05	0.00134	CbGpPWpGaD
Paliperidone—Rash—Dexamethasone—allergic rhinitis	1.96e-05	0.000169	CcSEcCtD
Paliperidone—Rash—Betamethasone—allergic rhinitis	1.96e-05	0.000169	CcSEcCtD
Paliperidone—Dermatitis—Dexamethasone—allergic rhinitis	1.96e-05	0.000169	CcSEcCtD
Paliperidone—Dermatitis—Betamethasone—allergic rhinitis	1.96e-05	0.000169	CcSEcCtD
Paliperidone—ADRA1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.95e-05	0.00132	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.95e-05	0.00132	CbGpPWpGaD
Paliperidone—Headache—Betamethasone—allergic rhinitis	1.95e-05	0.000168	CcSEcCtD
Paliperidone—Headache—Dexamethasone—allergic rhinitis	1.95e-05	0.000168	CcSEcCtD
Paliperidone—HRH1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.94e-05	0.00132	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	1.93e-05	0.00131	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	1.93e-05	0.00131	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CCL11—allergic rhinitis	1.91e-05	0.0013	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.91e-05	0.0013	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—IL5—allergic rhinitis	1.9e-05	0.00129	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	1.89e-05	0.00128	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CCL11—allergic rhinitis	1.88e-05	0.00128	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—TAC1—allergic rhinitis	1.86e-05	0.00126	CbGpPWpGaD
Paliperidone—Nausea—Dexamethasone—allergic rhinitis	1.85e-05	0.00016	CcSEcCtD
Paliperidone—Nausea—Betamethasone—allergic rhinitis	1.85e-05	0.00016	CcSEcCtD
Paliperidone—HTR2A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	1.84e-05	0.00125	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—TAC1—allergic rhinitis	1.84e-05	0.00125	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—IL5—allergic rhinitis	1.83e-05	0.00124	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—TAC1—allergic rhinitis	1.82e-05	0.00123	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.8e-05	0.00122	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PTGDR2—allergic rhinitis	1.79e-05	0.00122	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	1.79e-05	0.00122	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.77e-05	0.0012	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.77e-05	0.0012	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PTGDR2—allergic rhinitis	1.77e-05	0.0012	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.77e-05	0.0012	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	1.75e-05	0.00119	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CCL11—allergic rhinitis	1.74e-05	0.00118	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.73e-05	0.00118	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL5—allergic rhinitis	1.73e-05	0.00117	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—IL5—allergic rhinitis	1.71e-05	0.00116	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CCL11—allergic rhinitis	1.71e-05	0.00116	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CCL11—allergic rhinitis	1.7e-05	0.00116	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—IL5—allergic rhinitis	1.69e-05	0.00115	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CCL11—allergic rhinitis	1.67e-05	0.00114	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—TAC1—allergic rhinitis	1.67e-05	0.00114	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—TAC1—allergic rhinitis	1.65e-05	0.00112	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—TAC1—allergic rhinitis	1.64e-05	0.00111	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	1.62e-05	0.0011	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.61e-05	0.00109	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PTGDR2—allergic rhinitis	1.6e-05	0.00108	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.59e-05	0.00108	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	1.58e-05	0.00108	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—TAC1—allergic rhinitis	1.57e-05	0.00107	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	1.57e-05	0.00106	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CYSLTR1—allergic rhinitis	1.56e-05	0.00106	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	1.55e-05	0.00106	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL5—allergic rhinitis	1.55e-05	0.00106	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	1.54e-05	0.00105	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	1.53e-05	0.00104	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PTGDR2—allergic rhinitis	1.53e-05	0.00104	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL5—allergic rhinitis	1.53e-05	0.00104	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—TAC1—allergic rhinitis	1.53e-05	0.00104	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—IL5—allergic rhinitis	1.52e-05	0.00104	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCL11—allergic rhinitis	1.51e-05	0.00103	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—TAC1—allergic rhinitis	1.51e-05	0.00102	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PTGDR2—allergic rhinitis	1.49e-05	0.00101	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—TAC1—allergic rhinitis	1.49e-05	0.00101	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	1.47e-05	0.000999	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PTGDR2—allergic rhinitis	1.47e-05	0.000997	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—IL5—allergic rhinitis	1.46e-05	0.000994	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	1.44e-05	0.000976	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—TAC1—allergic rhinitis	1.43e-05	0.000971	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—IL5—allergic rhinitis	1.42e-05	0.000967	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.41e-05	0.000956	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—IL5—allergic rhinitis	1.4e-05	0.000952	CbGpPWpGaD
Paliperidone—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.39e-05	0.000947	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—TAC1—allergic rhinitis	1.39e-05	0.000945	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—TAC1—allergic rhinitis	1.39e-05	0.000944	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CYSLTR1—allergic rhinitis	1.39e-05	0.000943	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL5—allergic rhinitis	1.38e-05	0.00094	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—TAC1—allergic rhinitis	1.37e-05	0.00093	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.37e-05	0.000929	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—TAC1—allergic rhinitis	1.36e-05	0.000927	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL11—allergic rhinitis	1.36e-05	0.000923	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PTGDR2—allergic rhinitis	1.35e-05	0.00092	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL11—allergic rhinitis	1.34e-05	0.000911	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—TAC1—allergic rhinitis	1.34e-05	0.000909	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	1.34e-05	0.000908	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.33e-05	0.000905	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL5—allergic rhinitis	1.33e-05	0.000903	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTGDR2—allergic rhinitis	1.33e-05	0.000903	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTGDR2—allergic rhinitis	1.3e-05	0.000886	CbGpPWpGaD
Paliperidone—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.3e-05	0.000885	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL5—allergic rhinitis	1.29e-05	0.000878	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—IL5—allergic rhinitis	1.29e-05	0.000878	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL5—allergic rhinitis	1.27e-05	0.000864	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—IL5—allergic rhinitis	1.27e-05	0.000863	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—IL5—allergic rhinitis	1.27e-05	0.000862	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—TAC1—allergic rhinitis	1.26e-05	0.000857	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.25e-05	0.000851	CbGpPWpGaD
Paliperidone—HRH1—nose—allergic rhinitis	1.25e-05	0.253	CbGeAlD
Paliperidone—ADRA1A—GPCR downstream signaling—IL5—allergic rhinitis	1.24e-05	0.000845	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.24e-05	0.000845	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—TAC1—allergic rhinitis	1.24e-05	0.000843	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—TAC1—allergic rhinitis	1.24e-05	0.000842	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—TAC1—allergic rhinitis	1.22e-05	0.000826	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.21e-05	0.000823	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL11—allergic rhinitis	1.21e-05	0.000822	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.21e-05	0.000822	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CYSLTR1—allergic rhinitis	1.2e-05	0.000818	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL5—allergic rhinitis	1.17e-05	0.000797	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CYSLTR1—allergic rhinitis	1.17e-05	0.000795	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	1.17e-05	0.000794	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL11—allergic rhinitis	1.16e-05	0.00079	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	1.16e-05	0.000786	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL5—allergic rhinitis	1.15e-05	0.000784	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.15e-05	0.000783	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL5—allergic rhinitis	1.15e-05	0.000782	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	1.14e-05	0.000773	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL11—allergic rhinitis	1.13e-05	0.000768	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL5—allergic rhinitis	1.13e-05	0.000768	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	1.13e-05	0.000767	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	1.11e-05	0.000757	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL11—allergic rhinitis	1.11e-05	0.000756	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TAC1—allergic rhinitis	1.1e-05	0.000745	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CYSLTR1—allergic rhinitis	1.06e-05	0.000722	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL5—allergic rhinitis	1.06e-05	0.000719	CbGpPWpGaD
Paliperidone—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.06e-05	0.000719	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	1.05e-05	0.000713	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.04e-05	0.00071	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.04e-05	0.000708	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL5—allergic rhinitis	1.04e-05	0.000704	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL11—allergic rhinitis	1.03e-05	0.000697	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.02e-05	0.000695	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL5—allergic rhinitis	1.02e-05	0.000693	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL11—allergic rhinitis	1.01e-05	0.000686	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL11—allergic rhinitis	1.01e-05	0.000684	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL11—allergic rhinitis	9.88e-06	0.000671	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TAC1—allergic rhinitis	9.87e-06	0.000671	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TAC1—allergic rhinitis	9.74e-06	0.000662	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	9.51e-06	0.000646	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	9.18e-06	0.000624	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL5—allergic rhinitis	9.18e-06	0.000623	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL5—allergic rhinitis	9.05e-06	0.000615	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TAC1—allergic rhinitis	8.79e-06	0.000597	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	8.49e-06	0.000577	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TAC1—allergic rhinitis	8.44e-06	0.000574	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TAC1—allergic rhinitis	8.21e-06	0.000558	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL5—allergic rhinitis	8.17e-06	0.000555	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TAC1—allergic rhinitis	8.08e-06	0.000549	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL5—allergic rhinitis	7.89e-06	0.000536	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL5—allergic rhinitis	7.85e-06	0.000533	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL5—allergic rhinitis	7.64e-06	0.000519	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL5—allergic rhinitis	7.51e-06	0.000511	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TAC1—allergic rhinitis	7.45e-06	0.000506	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	7.45e-06	0.000506	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TAC1—allergic rhinitis	7.33e-06	0.000498	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TAC1—allergic rhinitis	7.32e-06	0.000497	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	7.29e-06	0.000495	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—TGFB1—allergic rhinitis	7.19e-06	0.000488	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TAC1—allergic rhinitis	7.18e-06	0.000488	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SMAD3—allergic rhinitis	7.17e-06	0.000487	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL5—allergic rhinitis	6.93e-06	0.000471	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL5—allergic rhinitis	6.82e-06	0.000463	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL5—allergic rhinitis	6.8e-06	0.000462	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—TGFB1—allergic rhinitis	6.71e-06	0.000456	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL5—allergic rhinitis	6.68e-06	0.000454	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	6.67e-06	0.000453	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SMAD3—allergic rhinitis	6.46e-06	0.000439	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SMAD3—allergic rhinitis	6.37e-06	0.000433	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	6.2e-06	0.000421	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SMAD3—allergic rhinitis	5.75e-06	0.000391	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	5.55e-06	0.000377	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SMAD3—allergic rhinitis	5.53e-06	0.000375	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	5.45e-06	0.00037	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SMAD3—allergic rhinitis	5.37e-06	0.000365	CbGpPWpGaD
Paliperidone—HTR2A—autonomic nervous system—allergic rhinitis	5.33e-06	0.108	CbGeAlD
Paliperidone—ADRA1B—Signaling Pathways—SMAD3—allergic rhinitis	5.29e-06	0.000359	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SMAD3—allergic rhinitis	4.88e-06	0.000331	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SMAD3—allergic rhinitis	4.8e-06	0.000326	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SMAD3—allergic rhinitis	4.79e-06	0.000325	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SMAD3—allergic rhinitis	4.7e-06	0.000319	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	4.37e-06	0.000297	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	3.78e-06	0.000257	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	3.71e-06	0.000252	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NFKB1—allergic rhinitis	3.65e-06	0.000248	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NFKB1—allergic rhinitis	3.28e-06	0.000223	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NFKB1—allergic rhinitis	3.24e-06	0.00022	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	3.15e-06	0.000214	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	3.09e-06	0.00021	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—allergic rhinitis	3.04e-06	0.000206	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NFKB1—allergic rhinitis	2.92e-06	0.000199	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	2.82e-06	0.000192	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NFKB1—allergic rhinitis	2.81e-06	0.000191	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—allergic rhinitis	2.73e-06	0.000186	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NFKB1—allergic rhinitis	2.73e-06	0.000186	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—allergic rhinitis	2.7e-06	0.000183	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NFKB1—allergic rhinitis	2.69e-06	0.000183	CbGpPWpGaD
Paliperidone—HTR1D—eye—allergic rhinitis	2.52e-06	0.0509	CbGeAlD
Paliperidone—DRD2—Signaling Pathways—NFKB1—allergic rhinitis	2.48e-06	0.000168	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NFKB1—allergic rhinitis	2.44e-06	0.000166	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—allergic rhinitis	2.44e-06	0.000166	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NFKB1—allergic rhinitis	2.43e-06	0.000165	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NFKB1—allergic rhinitis	2.39e-06	0.000162	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	2.35e-06	0.00016	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—allergic rhinitis	2.34e-06	0.000159	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—allergic rhinitis	2.28e-06	0.000155	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—allergic rhinitis	2.24e-06	0.000152	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	2.22e-06	0.000151	CbGpPWpGaD
Paliperidone—DRD2—respiratory system—allergic rhinitis	2.08e-06	0.042	CbGeAlD
Paliperidone—DRD2—Signaling Pathways—TGFB1—allergic rhinitis	2.06e-06	0.00014	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—allergic rhinitis	2.03e-06	0.000138	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—allergic rhinitis	2.03e-06	0.000138	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—allergic rhinitis	1.99e-06	0.000135	CbGpPWpGaD
Paliperidone—DRD2—eye—allergic rhinitis	1.9e-06	0.0384	CbGeAlD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	1.85e-06	0.000126	CbGpPWpGaD
Paliperidone—ADRA1A—epithelium—allergic rhinitis	1.77e-06	0.0358	CbGeAlD
Paliperidone—CYP3A5—respiratory system—allergic rhinitis	1.69e-06	0.0342	CbGeAlD
Paliperidone—ADRA2C—bronchus—allergic rhinitis	1.66e-06	0.0336	CbGeAlD
Paliperidone—HRH1—respiratory system—allergic rhinitis	1.64e-06	0.0332	CbGeAlD
Paliperidone—HRH1—eye—allergic rhinitis	1.5e-06	0.0303	CbGeAlD
Paliperidone—ADRA2C—trachea—allergic rhinitis	1.49e-06	0.0302	CbGeAlD
Paliperidone—HRH1—epithelium—allergic rhinitis	1.37e-06	0.0277	CbGeAlD
Paliperidone—HTR2A—respiratory system—allergic rhinitis	1.37e-06	0.0277	CbGeAlD
Paliperidone—ADRA2A—bronchus—allergic rhinitis	1.33e-06	0.0268	CbGeAlD
Paliperidone—HTR2A—eye—allergic rhinitis	1.25e-06	0.0253	CbGeAlD
Paliperidone—HRH1—trachea—allergic rhinitis	1.21e-06	0.0245	CbGeAlD
Paliperidone—ADRA2A—trachea—allergic rhinitis	1.19e-06	0.0241	CbGeAlD
Paliperidone—HTR2A—epithelium—allergic rhinitis	1.15e-06	0.0231	CbGeAlD
Paliperidone—DRD2—lung—allergic rhinitis	1.1e-06	0.0223	CbGeAlD
Paliperidone—ADRA2C—lung—allergic rhinitis	1.07e-06	0.0217	CbGeAlD
Paliperidone—HTR2A—trachea—allergic rhinitis	1.01e-06	0.0205	CbGeAlD
Paliperidone—CYP3A5—lung—allergic rhinitis	8.98e-07	0.0181	CbGeAlD
Paliperidone—HRH1—lung—allergic rhinitis	8.72e-07	0.0176	CbGeAlD
Paliperidone—ADRA2A—lung—allergic rhinitis	8.56e-07	0.0173	CbGeAlD
Paliperidone—HTR2A—lung—allergic rhinitis	7.28e-07	0.0147	CbGeAlD
